OXFORD CANNABINOID TECHNOLOGIES
Oxford Cannabinoid Technologies brings together some of the world’s best medical researchers to develop new therapies for diseases with high unmet medical need.
Our lead academic partner is the University of Oxford, with whom we have launched a large-scale cannabinoid research program that investigates the medical potential of cannabinoids across different therapeutic areas. OCT combines Oxford’s world leading research and clinical expertise with UK investment firm Kingsley’s network of experts and financial support.
OCT uses 21st century technology and drug development standards to explore the potential of cannabinoid medication and bring treatments to the market.
If you are a clinician, principal investigator, or investor and would like to know more about OCT, please contact us through the details on our contact page. If you are a patient interested in clinical trials, please complete our form on the clinical trials page.
We look forward to hearing from you.
Cannabinoid-based therapies have a very wide range of potential medical applications, many of which will be explored by Oxford Cannabinoid Technologies. Current areas of focus include inflammatory diseases, pain management, cancer, and neurological disorders.